首页 | 本学科首页   官方微博 | 高级检索  
     


Phase I Study of Vandetanib With Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma
Authors:Jan Drappatz  Andrew D. Norden  Eric T. Wong  Lisa M. Doherty  Debra C. LaFrankie  Abigail Ciampa  Santosh Kesari  Christine Sceppa  Mary Gerard  Phuong Phan  David Schiff  Tracy T. Batchelor  Keith L. Ligon  Geoffrey Young  Alona Muzikansky  Stephanie E. Weiss  Patrick Y. Wen
Affiliation: Center for Neuro-Oncology, Dana Farber/Brigham and Women''s Cancer Center, Boston, MA;# Center for Molecular Oncologic Pathology, Dana Farber/Brigham and Women''s Cancer Center, Boston, MA;‡‡ Department of Radiation Oncology, Dana Farber/Brigham and Women''s Cancer Center, Boston, MA; Division of Cancer Neurology, Department of Neurology, Brigham and Women''s Hospital, Boston, MA;∗∗ Divison of Neuroradiology, Department of Radiology, Brigham and Women''s Hospital, Boston, MA; Harvard Medical School, Boston, MA;§ Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA; Department of Neurology, Division of Neuro-Oncology, University of Virginia Health Sciences Center, Charlottesville, VA;|| Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA;†† Massachusetts General Hospital Biostatistics Center, Boston, MA
Abstract:
Keywords:Glioblastoma   vandetanib   radiotherapy   temozolomide
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号